Twenty-eight women diagnosed with breast cancer were tested for TP53 mutations; two of them (7.1%) were found to carry a pathogenic mutation, heterozygous TP53 p.R337H (Figure 1). The gene discussed is TP53; the disease is breast carcinoma.